影响功能恢复指导心脏综合征患者VexUS的脱血:一:随机对照试验
J P Islas-Rodríguez1,2, Tomas Miranda-Aquino1, Gregorio Romero-González3
1Cardiology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
Cardiorenal medicine
|December 7, 2023
概括
以超声波进行静脉评估 (VExUS) 引导的脱血没有改善1型心综合征 (CRS1) 中的功能恢复. 然而,VExUS显著提高了脱塞成功率和大脑天然尿素 (BNP) 减少.
科学领域:
- 心脏病医疗 - 心脏病医疗
- 诊断性超声波 超声波 超声波 超声波
- 心脏衰竭管理的管理
背景情况:
- 血管拥堵是心综合征1型 (CRS1) 病理生理学的核心,使解堵成为关键的治疗目标.
- 以超声波进行静脉评估 (VExUS) 系统提供了一种潜在的方法,可以更有效地指导排挤策略.
- 在CRS1中优化脱塞可能会改善患者的治疗结果,并减少医疗保健利用率.
研究的目的:
- 与CRS1.1患者的标准临床评估相比,评估VExUS引导脱血的疗效.
- 确定VExUS指南对功能恢复 (KFR) 作为主要终点的影响.
- 评估二级终点,包括身体脱血,大脑天然尿素 (BNP) 和CA-125水平.
主要方法:
- 一项随机临床试验,涉及140名患有CRS1的患者 (定义为肌素增加≥0.3 mg/dL).
- 患者被随机分为1:1分别接受VExUS引导的脱血或通常的临床评估.
- 主要终点是KFR;次要终点包括脱塞评估,BNP和CA-125变化.
主要成果:
- 在VExUS和对照组之间没有观察到KFR的统计学上显著差异.
- 根据VexUS的指导,实现脱堵的几率显著增加 (OR:2.6,p=0.01) 和减少BNP>30% (OR:2.4,p=0.01).
- 九十天的存活率,再堵塞率和CA-125水平在两组之间是相似的.
结论:
- 在CRS1患者中,VExUS引导的脱血并没有改善功能恢复.
- 在VExUS指南中,在实现临床脱血和降低BNP水平方面显示出显著的益处.
- 需要进一步的研究,以充分阐明VExUS在优化CRS1管理中的作用.
相关概念视频
01:22Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:17Factors Affecting Renal Clearance: Renal Impairment
98
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
98
01:11Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
01:25Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
648
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
648